Figure 9 from OPG-Producing B Cells and RANKL-Expressing T Cells Define Immune Signatures Predictive of Bone Metastases in Breast Cancer

Read full text
Authors: Ana Carolina Monteiro, Diego D. Garcia, Ana Paula Gregório Alves Fontão, Bárbara Du Rocher, Maria E. Globa Masset, Isabella N. Alves, Lucas Gonçalves Carvalho, Cecília Vianna De Andrade, Gabriel Fidalgo, Marcos V. Colaço, Liebert Parreiras Nogueira, Maria de Fátima Dias Gauí
+1 more Adriana Bonomo
Cited by: 0

Abstract

Opposing infiltration patterns of RANKL+ and OPG+ lymphocytes in primary tumors of patients with TNBC with or without bone metastases. A, Quantification of tumor-infiltrating CD3+ T cells in primary tumor samples from patients with TNBC who later developed BoneMet (n = 5) vs. those who remained No BoneMet (n = 5). Data are shown as box and whisker plots with individual values, and statistical comparison was performed by unpaired two-tailed Student t test (P = 0.0247); variance homogeneity was verified by F test (P = 0.0984). B, Representative IHC images of CD3+ T cells in primary tumors from each patient group. C, Quantification of RANKL+ lymphocytes in the same cohort, also expressed as box and whisker plots with overlaid points. Statistical analysis: Mann–Whitney U test (P = 0.0278) and confirmatory unpaired two-tailed t test (P = 0.0173), with F test confirming homogeneity of variance (P = 0.2850). D, Representative images of RANKL staining in tumor sections from BoneMet and No BoneMet patients. E, Quantification of CD20+ B cells in the same tumor samples. Although not statistically significant (P = 0.1323) by unpaired two-tailed t test, a higher median infiltration was observed in the No BoneMet group, and F test for variance (P = 0.1287). F, Representative IHC images of CD20 staining showing differences in localization and density between groups. G, Quantification of OPG+ lymphocytes in No BoneMet tumors compared with BoneMet. Median values were 50.95% (No BoneMet) and 17.31% (BoneMet). Statistical analysis: unpaired two-tailed t test (P = 0.0341) with variance verified by F test (P = 0.6365); the Mann–Whitney U test showed a consistent trend (P = 0.0556). H, Representative images of OPG+ cells from each group. Statistical assumptions were verified using the F test for variance homogeneity. Due to the limited sample size, nonparametric tests were prioritized, and parametric results were used as confirmatory evidence.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Breast Cancer Treatment Studies T-cell and B-cell Immunology

Publication details

Publication date
13 January 2026